| Dr Ahmad Munir Al Rubaie, PHARMD | |
|
3700 W Saginaw St, Lansing, MI 48917-2290 | |
| (517) 321-7746 | |
| Not Available |
| Full Name | Dr Ahmad Munir Al Rubaie |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 3700 W Saginaw St, Lansing, Michigan |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063006237 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 5302412544 (Michigan) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ahmad Munir Al Rubaie, PHARMD 3700 W Saginaw St, Lansing, MI 48917-2290 Ph: (517) 321-7746 | Dr Ahmad Munir Al Rubaie, PHARMD 3700 W Saginaw St, Lansing, MI 48917-2290 Ph: (517) 321-7746 |
News Archive
Atherosclerosis is one of the commonest causes of death in modern societies. The condition is characterized by the build-up of fatty deposits called atherosclerotic plaques on the inner surfaces of arteries, which restrict, and may eventually cut off, blood flow. The deposits can also be dislodged from their site of origin and may then block major vessels in the heart or the brain, leading to life-threatening myocardial infarction or stroke.
Six new stem cell therapies, all forecast to reach physicians in 2010, will be featured at the 5th Annual Stem Cell Summit on February 16 in New York City. These new therapies include allograft products, innovative forms of autologous stem cell technologies, and at least one FDA-approved stem cell drug. New studies showing rehydration of the disc nucleus, regeneration of new heart muscle and others are also on the agenda.
Patients who watch an online instructional video are more likely to keep their appointments and arrive prepared for a scheduled colonoscopy than those who do not, according to a study by gastroenterologists at the University of Chicago Medicine.
Once-daily treatment of patients with chronic obstructive pulmonary disease (COPD) with an inhaler combining fluticasone furoate (FF), umeclidinium (UMEC) and vilanterol (VI) reduced all-cause mortality by 42 percent, according to new research published online in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.
› Verified 2 days ago
Mr. Suresh Kumar Komirisetty, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1705 W Mount Hope Ave, Lansing, MI 48910 Phone: 517-372-6700 Fax: 517-372-0616 | |
Dr. Christine Dittenber, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 409 N Marketplace Blvd, Lansing, MI 48917 Phone: 517-622-1451 | |
Stanley John Budzynski, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1019 W Saginaw St, Lansing, MI 48915 Phone: 517-374-6103 | |
Jordan Onopa, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3915 W Saginaw Hwy, Lansing, MI 48917 Phone: 517-703-0593 Fax: 517-703-0597 | |
Almutasm Nassr, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1515 Lake Lansing Rd Ste B, Lansing, MI 48912 Phone: 517-730-0999 | |
Dr. Sarah Mercke Barden, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 408 Kalamazoo Plz, Lansing, MI 48933 Phone: 517-377-0240 | |
Mr. Venkata Satyanarayana Majeti, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2701 S Cedar St, Lansing, MI 48910 Phone: 517-272-9190 |